Surprisingly, the efficacy of the combined diagnosis in distinguishing HCC patients from healthy controls as well as patients with cirrhosis or hepatitis B was higher than that using serum AFP levels or plasma hsa_circ_0001445 levels alone. This evidence concerns the gene AFP and hepatocellular carcinoma.